400-998-5282
专注多肽 服务科研
NEP(1-40) 是 Nogo-66 受体 (NgR) 的肽类拮抗剂,通过限制髓蛋白抑制逆转损伤引起的小胶质细胞形态分布的改变。
编号:431064
CAS号:475221-20-6
单字母:Ac-RIYKGVIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNS-CONH2
NEP(1-40) 是 Nogo-66 受体 (NgR) 的肽类拮抗剂,通过限制髓蛋白抑制逆转损伤引起的小胶质细胞形态分布的改变。
Nogo-66 (1-40) is a peptide that is used as a research tool in cell biology, pharmacology and neuroscience. It is an inhibitor of the receptor for nerve growth factor (NGF), which has been shown to inhibit the activity of Nogo-A, a protein that prevents axonal growth. Nogo-66 (1-40) binds to the Nogo receptor on cells and blocks its ability to bind with NGF, preventing it from inhibiting axonal growth. This antibody can be used in research on ion channels, protein interactions and receptors.
[1] Jos P Leite, et al. Aβ 31-35 Decreases Neprilysin-Mediated Alzheimer's Amyloid-β Peptide Degradation
https://pubmed.ncbi.nlm.nih.gov/34505762
[2] Yan Lin, et al. NEP 1-40-modified human serum albumin nanoparticles enhance the therapeutic effect of methylprednisolone against spinal cord injury
https://pubmed.ncbi.nlm.nih.gov/30670038
[3] Jos P Leite, et al. Alzheimer's Aβ 1-40 peptide degradation by thermolysin: evidence of inhibition by a C-terminal Aβ product
https://pubmed.ncbi.nlm.nih.gov/30403288
[4] Zhou Zhilai, et al. Combination of NEP 1-40 infusion and bone marrow-derived neurospheres transplantation inhibit glial scar formation and promote functional recovery after rat spinal cord injury
https://pubmed.ncbi.nlm.nih.gov/21891937
[5] Pei-chun Fang, et al. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats
https://pubmed.ncbi.nlm.nih.gov/20075346